In the last decades, a lot of attention has been paid to the compounds present in medicinal Cannabis sativa L., such as THC and CBD, and their effects on inflammation and cancer-related pain. The National Cancer Institute (NCI) currently recognizes medicinal C. sativa as an effective treatment for providing relief in a number of symptoms associated with cancer, including pain, loss of appetite, nausea and vomiting, and anxiety.
Several studies have described CBD acting as an adaptogen, and as a modulator, in different ways mainly interacting with specific receptor proteins CB1 and CB2. CBD is present in both medicinal and fibre-type C. sativa plants, but, unlike Δ9-THC, it is completely nonpsychoactive.
